TrialBritish journal of haematology2016

Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib.

Tim H Brümmendorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.